Effectiveness and efficiency of targeted intra-operative single dose radiotherapy for breast cancer patients confirmed

New long-term results from the international TARGIT-A breast cancer study, based on ZEISS technology, have been published1 JENA/ GERMANY, August 26, 2020 Use of targeted intra-operative radiotherapy (TARGIT), as a single dose – with ZEISS INTRABEAM – directly after removal of a tumor, confirmed as non-inferior, when compared with external beam radiotherapy (EBRT). Within the … Skaityti toliau

The Mary Kay Foundation Donates $100,000 to Baylor Scott & White to Support Triple Negative Breast Cancer Research

DALLAS–(BUSINESS WIRE)–The Mary Kay FoundationSM, a decades-long leader in the mission to eliminate cancers affecting women, recently donated $100,000 to Baylor Scott & White Dallas Foundation to help fund research conducted by Dr. Joyce O’Shaughnessy, breast oncologist with TEXAS Oncology and the Celebrating Women Chair in breast cancer research at Baylor University Medical Center. Dr. … Skaityti toliau

Invitation: 12th St.Gallen International Breast Cancer Conference, March 16-19, 2011

St.Gallen, Switzerland – This bi-annual conference will highlight meaningful advances concerning treatment of Early Breast Cancer (EBC). The conference will build up on earlier diagnostic and therapeutic recommendations and thereafter provide written guidelines for the international community. Breast cancer specialists from all over the world are awaiting these new guidelines. The highlights: 1. Until recently, … Skaityti toliau